Table 2.
Ki values [nM] for the inhibition of PR mutants by clinically available inhibitors lopinavir, ritonavir, saquinavir, amprenavir, indinavir, atazanavir, and brecanavir
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.